Stock Chart
PEN
Type: SELL growth_1yr
Strike: $340
Premium: $18.40
Expiry: Jun 17, 2027
Target: $317
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About PEN - Penumbra, Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Key Statistics
More PEN Analysis
This PEN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track PEN's price movements with trendlines, gamma walls, and key support/resistance levels.